Search Legislation

Misuse of Drugs Act 1971

What Version

 Help about what version

Advanced Features

 Help about advanced features

Changes to legislation:

There are outstanding changes not yet made by the legislation.gov.uk editorial team to Misuse of Drugs Act 1971. Any changes that have already been made by the team appear in the content and are referenced with annotations. Help about Changes to Legislation

Close

Changes to Legislation

Revised legislation carried on this site may not be fully up to date. Changes and effects are recorded by our editorial team in lists which can be found in the ‘Changes to Legislation’ area. Where those effects have yet to be applied to the text of the legislation by the editorial team they are also listed alongside the legislation in the affected provisions. Use the ‘more’ link to open the changes and effects relevant to the provision you are viewing.

Changes and effects yet to be applied to :

 Help about changes and effects
Close

Changes and effects

This section lists the changes and effects yet to be applied to the specific provision you are viewing.

Changes and effects yet to be applied to the whole Act associated Parts and Chapters:

 Help about changes and effects
Close

Changes and effects

This section lists the changes and effects yet to be applied to the whole Act, associated Parts and Chapters where applicable. This includes any insertions of whole new Parts, Chapters or provisions yet to be inserted into this Act. These effects are included in this view as they may be (but won’t necessarily be) relevant to the specific provision that you are viewing.

Whole provisions yet to be inserted into this Act (including any effects on those provisions):

Commencement Orders yet to be applied to the Misuse of Drugs Act 1971

 Help about changes and effects
Close

Commencement Orders

This section lists the commencement orders yet to be applied to the whole Act. These effects are included in this view as they may be (but won’t necessarily be) relevant to the specific provision that you are viewing. Where applicable the commencement orders are listed under two headings, firstly those that bring some part of the Act you are viewing into force and secondly, those that bring into force legislation that affects some part of the legislation you are viewing. If you are viewing a prospective version or there is a prospective version available there may be commencement orders listed here that are relevant to the provision you are viewing.

Section 2.

SCHEDULE 2E+W+S+N.I. Controlled Drugs

Part IE+W+S+N.I. Class A Drugs

1The following substances and products, namely:—E+W+S+N.I.

Acetorphine.Lysergamide.
[F1Alfentanil.]Lysergide and otherN-alkyl derivatives of lysergamide.
Allylprodine.Mescaline.
Alphacetylmethadol.Metazocine.
Alphameprodine.Methadone.
Alphamethadol.Methadyl acetate.
Alphaprodine.Methyldesorphine.
Anileridine.Methyldihydromorphine (6-methyldihydromorphine).
Benzethidine.Metopon.
Benzylmorphine (3-benzylmorphine).Morpheridine.
Betacetylmethadol.Morphine.
Betameprodine.Morphine methobromide, morphineN-oxide and other pentavalent nitrogen morphine derivatives.
Betamethadol.Myrophine.
Betaprodine. . . . F2
Bezitramide.Nicomorphine (3,6-dinicotinoylmorphine).
Bufotenine.Noracymethadol.
Cannabinol, except where contained in cannabis or cannabis resin.Norlevorphanol.
Cannabinol derivatives.Normethadone.
[F3Carfentanil.]Normorphine.
Clonitazene.Norpipanone.
Coca leaf.Opium, whether raw, prepared or medicinal.
Cocaine.Oxycodone.
Desomorphine.Oxymorphone.
Dextromoramide.Pethidine.
Diamorphine.Phenadoxone.
Diampromide.Phenampromide.
Diethylthiambutene.Phenazocine.
[F4Difenoxin (1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylic acid).][F5Phencyclidine.]
DihydrocodeinoneO-carboxymethyloxime.Phenomorphan.
Dihydromorphine.Phenoperidine.
Dimenoxadole.Piminodine.
Dimepheptanol.Piritramide.
Dimethylthiambutene.Poppy-straw and concentrate of poppy-straw.
Dioxaphetyl butyrate.Proheptazine.
Diphenoxylate.Properidine (1-methyl-4-phenyl-piperidine-4-carboxylic acid isopropyl ester).
Dipipanone.Psilocin.
[F6Drotebanol (3,4-dimethoxy-17-methylmorphinan-6b, 14-diol).]Racemethorphan.
Ecgonine, and any derivative of ecgonine which is convertible to ecgonine or to cocaine.Racemoramide.
Ethylmethylthiambutene.Racemorphan.
[F1Eticyclidine.][F1Rolicyclidine.]
Etonitazene.[F7Sufentanil.]
Etorphine.[F1Tenocylidine.]
Etoxeridine.Thebacon.
[F8Etryptamine]
Fentanyl.Thebaine.
Furethidine.[F7Tilidate.]
Hydrocodone.Trimeperidine.
Hydromorphinol.[F94-Bromo-2,5-dimethoxy-a-methylphenethylamine].
Hydromorphone.4-Cyano-2-dimethylamino-4,4-diphenylbutane.
Hydroxypethidine.4-Cyano-1-methyl-4-phenyl-piperidine.
Isomethadone.N,N-Diethyltryptamine.
Ketobemidone.N,N-Dimethyltryptamine.
Levomethorphan.2,5-Dimethoxy-a,4-dimethylphenethylamine.
Levomoramide.[F10N-Hydroxy-tenamphetamine.]
Levophenacylmorphan.1-Methyl-4-phenylpiperidine-4-carboxylic acid.
Levorphanol.2-Methyl-3-morpholino-1, 1-diphenylpropanecarboxylic acid.
[F3Lofentanil][F114-Methyl-aminorex]
4-Phenylpiperidine-4-carboxylic acid ethyl ester.
Annotations: Help about Annotation
Close

Annotations are used to give authority for changes and other effects on the legislation you are viewing and to convey editorial information. They appear at the foot of the relevant provision or under the associated heading. Annotations are categorised by annotation type, such as F-notes for textual amendments and I-notes for commencement information (a full list can be found in the Editorial Practice Guide). Each annotation is identified by a sequential reference number. For F-notes, M-notes and X-notes, the number also appears in bold superscript at the relevant location in the text. All annotations contain links to the affecting legislation.

Amendments (Textual)

F1Word inserted by S.I. 1984/859, art. 2(2)

F2Words repealed by S.I. 1973/771, art. 2

F3Word inserted by S.I. 1986/2230, art. 2(2)(a)

F4Word inserted by S.I. 1975/421, art. 3

F5Word inserted by S.I. 1979/299, art. 2

F6Word inserted by S.I. 1973/771, art. 2

F7Word inserted by S.I. 1983/765, art. 2(a)

F8Sch. 2 Pt. I para. 1(a): Word inserted (1.5.1998) by S.I. 1998/750, art.2(2)

F9Words inserted by S.I. 1975/421, art. 3

[F12(b)any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from tryptamine or from a ring-hydroxy tryptamine by substitution at the nitrogen atom of the sidechain with one or more alkyl substituents but no other substituent;

(c)any compound (not being methoxyphenamine or a compound for the time being specified in sub-paragraph (a) above) structurally derived from phenethylamine anN-alkylphenethylamine,a-methylphenethylamine, anN-alkyl-a-methylphenethylamine,a-ethylphenethylamine, or anN-alkyl-a-ethylphenethylamine by substitution in the ring to any extent with alkyl, alkoxy, alkylenedioxy or halide substituents, whether or not further substituted in the ring by one or more other univalent substituents.]

[F13(d)any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from fentanyl by modification in any of the following ways, that is to say,

(i)by replacement of the phenyl portion of the phenethyl group by any heteromonocycle whether or not further substituted in the heterocycle;

(ii)by substitution in the phenethyl group with alkyl, alkenyl, alkoxy, hydroxy, halogeno, haloalkyl, amino or nitro groups;

(iii)by substitution in the piperidine ring with alkyl or alkenyl groups;

(iv)by substitution in the aniline ring with alkyl, alkoxy, alkylenedioxy, halogeno or haloalkyl groups;

(v)by substitution at the 4-position of the piperidine ring with any alkoxycarbonyl or alkoxyalkyl or acyloxy group;

(vi)by replacement of the N-propionyl group by another acyl group;

(e)any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from pethidine by modification in any of the following ways, that is to say,

(i)by replacement of the 1-methyl group by an acyl, alkyl whether or not unsaturated, benzyl or phenethyl group, whether or not further substituted;

(ii)by substitution in the piperidine ring with alkyl or alkenyl groups or with a propano bridge, whether or not further substituted;

(iii)by substitution in the 4-phenyl ring wiith alkyl, alkoxy, aryloxy, halogeno or haloalkyl groups;

(iv)by replacement of the 4-ethoxycarbonyl by any other alkoxycarbonyl or any alkoxyalkyl or acyloxy group;

(v)by formation of an N-oxide or of a quaternary base.]

Annotations: Help about Annotation
Close

Annotations are used to give authority for changes and other effects on the legislation you are viewing and to convey editorial information. They appear at the foot of the relevant provision or under the associated heading. Annotations are categorised by annotation type, such as F-notes for textual amendments and I-notes for commencement information (a full list can be found in the Editorial Practice Guide). Each annotation is identified by a sequential reference number. For F-notes, M-notes and X-notes, the number also appears in bold superscript at the relevant location in the text. All annotations contain links to the affecting legislation.

Amendments (Textual)

F1Word inserted by S.I. 1984/859, art. 2(2)

F2Words repealed by S.I. 1973/771, art. 2

F3Word inserted by S.I. 1986/2230, art. 2(2)(a)

F4Word inserted by S.I. 1975/421, art. 3

F5Word inserted by S.I. 1979/299, art. 2

F6Word inserted by S.I. 1973/771, art. 2

F7Word inserted by S.I. 1983/765, art. 2(a)

F8Sch. 2 Pt. I para. 1(a): Word inserted (1.5.1998) by S.I. 1998/750, art.2(2)

F9Words inserted by S.I. 1975/421, art. 3

2Any stereoisomeric form of a substance for the time being specified in paragraph 1 above not being dextromethorphan or dextrorphan.E+W+S+N.I.

3Any ester or ether of a substance for the time being specified in paragraph 1 or 2 above [F14not being a substance for the time being specified in Part II of this Schedule].E+W+S+N.I.

Annotations: Help about Annotation
Close

Annotations are used to give authority for changes and other effects on the legislation you are viewing and to convey editorial information. They appear at the foot of the relevant provision or under the associated heading. Annotations are categorised by annotation type, such as F-notes for textual amendments and I-notes for commencement information (a full list can be found in the Editorial Practice Guide). Each annotation is identified by a sequential reference number. For F-notes, M-notes and X-notes, the number also appears in bold superscript at the relevant location in the text. All annotations contain links to the affecting legislation.

Amendments (Textual)

F14Words inserted by S.I. 1973/771, art. 2

4Any salt of a substance for the time being specified in any of paragraphs 1 to 3 above.E+W+S+N.I.

5Any preparation or other product containing a substance or product for the time being specified in any of paragraphs 1 to 4 above.E+W+S+N.I.

6Any preparation designed for administration by injection which includes a substance or product for the time being specified in any of paragraphs 1 to 3 of Part II of this Schedule.E+W+S+N.I.

Part IIE+W+S+N.I. Class B Drugs

1The following substances and products, namely:—E+W+S+N.I.

Acetyldihydrocodeine.Methylamphetamine [F17a-Methylphenethylhydroxylamine;].
Amphetamine.Methylphenidate.
Cannabis and cannabis resin.[F18Methylphenobarbitone.]
Codeine.Nicocodine.
. . . F19[F20Nicodicodine (6-nicotinoyldihydrocodeine).]
Dihydrocodeine.Norcodeine.
Ethylmorphine (3-ethylmorphine).[F21Pentazocine.]
[F22Glutethimide.]Phenmetrazine.
[F22Lefetamine.]Pholcodine.
[F18Mecloqualone.][F23Propiram.]
[F18Methaqualone.][F24Zipeprol]
[F24Methcathinone]
Annotations: Help about Annotation
Close

Annotations are used to give authority for changes and other effects on the legislation you are viewing and to convey editorial information. They appear at the foot of the relevant provision or under the associated heading. Annotations are categorised by annotation type, such as F-notes for textual amendments and I-notes for commencement information (a full list can be found in the Editorial Practice Guide). Each annotation is identified by a sequential reference number. For F-notes, M-notes and X-notes, the number also appears in bold superscript at the relevant location in the text. All annotations contain links to the affecting legislation.

Amendments (Textual)

F17Word in Sch. 2 Pt. II para. 1a inserted (1.2.2002) by S.I. 2001/3923, art. 2(3)

F18Word inserted by S.I. 1984/859, art. 2(3)

F19Word repealed by S.I. 1985/1995, art. 2(2)(a)

F20Words inserted by S.I. 1973/771, art. 2

F21Word inserted by S.I. 1985/1995, art. 2(2)(c)

F22Word inserted by S.I. 1985/1995, art. 2(2)(b)

F23Word inserted by S.I. 1973/771, art. 2

F24In Sch. 2 Pt. II para. 1(a): Word inserted (1.5.1998) by S.I. 1998/750, art. 2(3)(a),(b)

[F15(b)any 5,5 disubstituted barbituric acid.]

Annotations: Help about Annotation
Close

Annotations are used to give authority for changes and other effects on the legislation you are viewing and to convey editorial information. They appear at the foot of the relevant provision or under the associated heading. Annotations are categorised by annotation type, such as F-notes for textual amendments and I-notes for commencement information (a full list can be found in the Editorial Practice Guide). Each annotation is identified by a sequential reference number. For F-notes, M-notes and X-notes, the number also appears in bold superscript at the relevant location in the text. All annotations contain links to the affecting legislation.

Amendments (Textual)

F15Sub-para. (b) added by S.I. 1984/859, art. 2(3)

F16 “(a)” inserted by S.I. 1984/859, art. 2

F17Word in Sch. 2 Pt. II para. 1a inserted (1.2.2002) by S.I. 2001/3923, art. 2(3)

F18Word inserted by S.I. 1984/859, art. 2(3)

F19Word repealed by S.I. 1985/1995, art. 2(2)(a)

F20Words inserted by S.I. 1973/771, art. 2

F21Word inserted by S.I. 1985/1995, art. 2(2)(c)

F22Word inserted by S.I. 1985/1995, art. 2(2)(b)

F23Word inserted by S.I. 1973/771, art. 2

F24In Sch. 2 Pt. II para. 1(a): Word inserted (1.5.1998) by S.I. 1998/750, art. 2(3)(a),(b)

2Any stereoisomeric form of a substance for the time being specified in paragraph 1 of this Part of this Schedule.E+W+S+N.I.

3Any salt of a substance for the time being specified in paragraph 1 or 2 of this Part of this Schedule.E+W+S+N.I.

4Any preparation or other product containing a substance or product for the time being specified in any of paragraphs 1 to 3 of this Part of this Schedule, not being a preparation falling within paragraph 6 of Part I of this Schedule.E+W+S+N.I.

Part IIIE+W+S+N.I. Class C Drugs

1The following substances, namely:—E+W+S+N.I.

[F26Alprazolam.][F26Lorazepam.]
[F27Aminorex]
Benzphetamine.[F26Lormetazepam.]
[F26Bromazepam.][F26Mazindol.]
[F27Brotizolam]
[F28Buprenorphine][F26Medazepam.]
[F26Camazepam.][F29Mefenorex.]
[F29Cathine.] . . . F30
[F29Cathinone.]Mephentermine.
[F26Chlordiazepoxide.][F26Meprobamate.]
[F27Mesocarb]
Chlorphentermine. . . . F31
[F26Clobazam.][F26Methyprylone.]
[F26Clorazepic acid.][F32Midazolam.]
[F26Clonazepam.][F26Nimetazepam.]
[F26Clotiazepam.][F26Nitrazepam.]
[F26Cloxazolam.][F26Nordazepam.]
[F26Delorazepam.][F26Oxazepam.]
[F33Dextropropoxyphene.][F26Oxazolam.]
[F26Diazepam.][F34Pemoline.]
[F35Diethylpropion.] . . . F30
[F26Estazolam.]Phendimetrazine.
[F26Ethchlorvynol.][F26Phentermine.]
[F26Ethinamate.][F26Pinazepam.]
[F26Ethyl loflazepate.] . . . F30
[F29Fencamfamin.]Pipradrol.
[F29Fenethylline.][F26Prazepam.]
[F29Fenproporex.] . . . F30
[F26Fludiazepam.]F36. . .
[F26Flunitrazepam.][F29Pyrovalerone.]
[F26Flurazepam.][F26Temazepam.]
[F26Halazepam.][F26Tetrazepam.]
[F26Haloxazolam.][F26Triazolam.]
[F26Ketazolam.] [F29N-Ethylamphetamine.]
[F26Loprazolam.]
Annotations: Help about Annotation
Close

Annotations are used to give authority for changes and other effects on the legislation you are viewing and to convey editorial information. They appear at the foot of the relevant provision or under the associated heading. Annotations are categorised by annotation type, such as F-notes for textual amendments and I-notes for commencement information (a full list can be found in the Editorial Practice Guide). Each annotation is identified by a sequential reference number. For F-notes, M-notes and X-notes, the number also appears in bold superscript at the relevant location in the text. All annotations contain links to the affecting legislation.

Amendments (Textual)

F26Word inserted by S.I. 1985/1995, art. 2(3)

F27In Sch. 2 Pt. III para. 1(a) word inserted (1.5.1998) by S.I. 1998/750, art. 2(1)(4)(a)(b)(c)

F28Word inserted by S.I. 1989/1340, art. 2(a)

F29Word inserted by S.I. 1986/2230, art. 2(3)

F30Words repealed by S.I. 1973/771, art. 2

F31Word repealed by S.I. 1984/859, art. 2(4)(a)

F32Word inserted by S.I. 1990/2589, art. 2(b)

F33Word inserted by S.I. 1983/765, art. 2(a)

F34Word inserted by S.I. 1989/1340, art. 2(b)

F35Word inserted by S.I. 1984/859, art. 2(4)(a)

F36Word in Sch. 2 para.1 omitted (1.9.1995) by virtue of S.I. 1995/1966, art. 2

[F37(b)

Atamestane.

Bolandiol.

Bolasterone.

Bolazine.

Boldenone.

Bolenol.

Bolmantalate.

Calusterone.

4-Chloromethandienone.

Clostebol.

Drostanolone.

Enestebol.

Epitiostanol.

Ethyloestrenol.

Fluoxymesterone.

Formebolone.

Furazabol.

Mebolazine.

Mepitiostane.

Mesabolone.

Mestanolone.

Mesterolone.

Methandienone.

Methandriol.

Methenolone.

Methyltestosterone.

Metribolone.

Mibolerone.

Nandrolone.

Norboletone.

Norclostebol.

Norethandrolone.

Ovandrotone.

Oxabolone.

Oxandrolone.

Oxymesterone.

Oxymetholone.

Prasterone.

Propetandrol.

Quinbolone.

Roxibolone.

Silandrone.

Stanolone.

Stanozolol.

Stenbolone.

Testosterone.

Thiomesterone.

Trenbolone.

(c)any compound (not being Trilostane or a compound for the time being specified in sub-paragraph (b) above) structurally derived from 17-hydroxyandrostan-3-one or from 17-hydroxyestran-3-one by modification in any of the following ways, that is to say,

(i)by further substitution at position 17 by a methyl or ethyl group;

(ii)by substitution to any extent at one or more of positions 1, 2, 4, 6, 7, 9, 11 or 16, but at no other position;

(iii)by unsaturation in the carbocyclic ring system to any extent, provided that there are no more than two ethylenic bonds in any one carbocyclic ring;

(iv)by fusion of ring A with a heterocyclic system;

(d)any substance which is an ester or ether (or, where more than one hydroxyl function is available, both an ester and an ether) of a substance specified in sub-paragraph (b) or described in sub-paragraph (c) above;

(e)

  • Chorionic Gonadotrophin (HCG).

  • Clenbuterol.

    Non-human chorionic gonadotrophin.

    Somatotropin.

    Somatrem.

    Somatropin.]

Annotations: Help about Annotation
Close

Annotations are used to give authority for changes and other effects on the legislation you are viewing and to convey editorial information. They appear at the foot of the relevant provision or under the associated heading. Annotations are categorised by annotation type, such as F-notes for textual amendments and I-notes for commencement information (a full list can be found in the Editorial Practice Guide). Each annotation is identified by a sequential reference number. For F-notes, M-notes and X-notes, the number also appears in bold superscript at the relevant location in the text. All annotations contain links to the affecting legislation.

Amendments (Textual)

F25In Sch. 2 Pt. III para. 1, sub-para. (a) inserted (1.9.1996) by S.I. 1996/1300, art. 2(2)(a)

F26Word inserted by S.I. 1985/1995, art. 2(3)

F27In Sch. 2 Pt. III para. 1(a) word inserted (1.5.1998) by S.I. 1998/750, art. 2(1)(4)(a)(b)(c)

F28Word inserted by S.I. 1989/1340, art. 2(a)

F29Word inserted by S.I. 1986/2230, art. 2(3)

F30Words repealed by S.I. 1973/771, art. 2

F31Word repealed by S.I. 1984/859, art. 2(4)(a)

F32Word inserted by S.I. 1990/2589, art. 2(b)

F33Word inserted by S.I. 1983/765, art. 2(a)

F34Word inserted by S.I. 1989/1340, art. 2(b)

F35Word inserted by S.I. 1984/859, art. 2(4)(a)

F36Word in Sch. 2 para.1 omitted (1.9.1995) by virtue of S.I. 1995/1966, art. 2

F37In Sch. 2 Pt. III para. 1, sub-para. (b) to sub-para. (e) added (1.9.1996) by S.I. 1996/1300, art. 2(2)(b)

2Any stereoisomeric form of a substance for the time being specified in paragraph 1 of this Part of this Schedule [F38not being phenylpropanolamine.]E+W+S+N.I.

Annotations: Help about Annotation
Close

Annotations are used to give authority for changes and other effects on the legislation you are viewing and to convey editorial information. They appear at the foot of the relevant provision or under the associated heading. Annotations are categorised by annotation type, such as F-notes for textual amendments and I-notes for commencement information (a full list can be found in the Editorial Practice Guide). Each annotation is identified by a sequential reference number. For F-notes, M-notes and X-notes, the number also appears in bold superscript at the relevant location in the text. All annotations contain links to the affecting legislation.

Amendments (Textual)

3Any salt of a substance for the time being specified in paragraph 1 or 2 of this Part of this Schedule.E+W+S+N.I.

4Any preparation or other product containing a substance for the time being specified in any of paragraphs 1 to 3 of this Part of this Schedule.E+W+S+N.I.

Part IVE+W+S+N.I. Meaning of certain Expressions used in this Schedule

For the purposes of this Schedule the following expressions (which are not among those defined in section 37(1) of this Act) have the meanings hereby assigned to them respectively, that is to say—

  • cannabinol derivatives” means the following substances, except where contained in cannabis or cannabis resin, namely tetrahydro derivatives of cannabinol and 3-alkyl homologues of cannabinol or of its tetrahydro derivatives;

  • coca leaf” means the leaf of any plant of the genusErythroxylonfrom whose leaves cocaine can be extracted either directly or by chemical transformation;

  • concentrate of poppy-straw” means the material produced when poppy-straw has entered into a process for the concentration of its alkaloids;

  • medicinal opium” means raw opium which has undergone the process necessary to adapt it for medicinal use in accordance with the requirements of the British Pharmacopoeia, whether it is in the form of powder or is granulated or is in any other form, and whether it is or is not mixed with neutral substances;

  • opium poppy” means the plant of the speciesPapaver somniferum L;

  • poppy straw” means all parts, except the seeds, of the opium poppy, after mowing;

  • raw opium” includes powdered or granulated opium but does not include medicinal opium.

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As Enacted or Made):The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.

Close

See additional information alongside the content

Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.

Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as enactedversion that was used for the print copy
  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as enacted version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources